The present study aimed to compare the surgical and oncological outcomes between young and older women with colorectal cancer (CRC).
Materials and Methods:
This retrospective study included 1815 women with CRC between 2010 and 2014. Participants were divided into a young group (under the age of 65 years) and an old group (65 years and older). The surgical and oncological outcomes were compared between the two groups using univariate and multivariate analyses.
Results:
Around 45.1% (N = 819) patients were the older group. The old group had a higher comorbidity rate and a lower proportion of receiving postoperative chemotherapy. The old group also had a significantly higher blood loss (190 ± 611 mL vs. 145 ± 200 mL, p = 0.027) and a higher rate of intraoperative transfusion (5.4% vs. 3.0%, p = 0.011). They were found to develop more complications after surgery (11.7% vs. 7.8%, p = 0.015). The overall survival (OS) of the old group was lower than that of the young group (5-year OS rates: 72.8% vs. 83.8%, p < 0.001; adjusted hazard ratio: 1.86, 95% confidence interval: 1.49–2.33). However, the cancer-specific survival (CSS) was not significantly different between the old and young groups (5-year CSS rates: 84.7% vs. 84.9%, p = 0.076).
Conclusions:
Older women with CRC had poorer OS than young women with CRC, but had similar CSS. Therefore, the management of comorbidities along with cancer treatment may be important in older women with CRC.
Get full access to this article
View all access options for this article.
References
1.
TorreLA, BrayF, SiegelRL, FerlayJ, Lortet-TieulentJ, JemalA. Global cancer statistics, 2012. CA Cancer J Clin, 2015; 65:87–108.
2.
ShaukatA, MonginSJ, GeisserMS, et al.Long-term mortality after screening for colorectal cancer. N Engl J Med, 2013; 369:1106–1114.
3.
FernandezE, BosettiC, VecchiaCL, LeviF, FiorettiF, NegriE. Sex differences in colorectal cancer mortality in Europe, 1955–1996. Eur J Cancer Prevent, 2000; 9:99–104.
4.
SmithRA, AndrewsKS, BrooksD, et al.Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin, 2017; 67:100–121.
5.
MoonSY, KimS, LeeSY, et al.Laparoscopic surgery for patients with colorectal cancer produces better short-term outcomes with similar survival outcomes in elderly patients compared to open surgery. Cancer Med, 2016; 5:1047–1054.
6.
ChungJ-Y, ChangW-Y, LinT-W, et al.An analysis of surgical outcomes in patients aged 80 years and older. Acta Anaesthesiol Taiwan, 2014; 52:153–158.
7.
MurthyVH, KrumholzHM, GrossCP. Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA, 2004; 291:2720–2726.
8.
LewisJH, KilgoreML, GoldmanDP, et al.Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol, 2003; 21:1383–1389.
9.
DindoD, DemartinesN, ClavienP-A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg, 2004; 240:205.
10.
PuntCJ, BuyseM, KohneCH, et al.Endpoints in adjuvant treatment trials: A systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst, 2007; 99:998–1003.
11.
YancikR, WesleyMN, RiesLA, et al.Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: A population-based study. Cancer, 1998; 82:2123–2134.
12.
BareM, MontonC, MoraL, et al.COPD is a clear risk factor for increased use of resources and adverse outcomes in patients undergoing intervention for colorectal cancer: A nationwide study in Spain. Int J Chron Obstruct Pulmon Dis, 2017; 12:1233–1241.
13.
PlatonAM, ErichsenR, ChristiansenCF, et al.The impact of chronic obstructive pulmonary disease on intensive care unit admission and 30-day mortality in patients undergoing colorectal cancer surgery: A Danish population-based cohort study. BMJ Open Respir Res, 2014; 1:e000036.
14.
EdwardsBK, NooneAM, MariottoAB, et al.Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer, 2014; 120:1290–1314.
15.
van LeersumNJ, Janssen-HeijnenML, WoutersMW, et al.Increasing prevalence of comorbidity in patients with colorectal cancer in the South of the Netherlands 1995–2010. Int J Cancer, 2013; 132:2157–2163.
16.
FerrarisVA, DavenportDL, SahaSP, AustinPC, ZwischenbergerJB. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Arch Surg, 2012; 147:49–55.
17.
WuWC, SmithTS, HendersonWG, et al.Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg, 2010; 252:11–17.
18.
BernardAC, DavenportDL, ChangPK, VaughanTB, ZwischenbergerJB. Intraoperative transfusion of 1U to 2U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg, 2009; 208:931–937, 937 e931–e932; discussion 938–939.
19.
RaghavanM, MarikPE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest, 2005; 127:295–307.
20.
HanEC, RyooS-B, ParkBK, et al.Surgical outcomes and prognostic factors of emergency surgery for colonic perforation: Would fecal contamination increase morbidity and mortality?. Int J Colorectal Dis, 2015; 30:1495–1504.
21.
IzaksGJ, WestendorpRG, KnookDL. The definition of anemia in older persons. JAMA, 1999; 281:1714–1717.
22.
KosiborodM, SmithGL, RadfordMJ, FoodyJM, KrumholzHM. The prognostic importance of anemia in patients with heart failure. Am J Med, 2003; 114:112–119.
23.
PenninxBW, PahorM, WoodmanRC, GuralnikJM. Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci, 2006; 61:474–479.
24.
KeelerBD, SimpsonJA, NgO, et al.Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer. Br J Surg, 2017; 104:214–221.
25.
BrownSR, MathewR, KedingA, MarshallHC, BrownJM, JayneDG. The impact of postoperative complications on long-term quality of life after curative colorectal cancer surgery. Ann Surg, 2014; 259:916–923.
26.
ArtinyanA, OrcuttST, AnayaDA, RichardsonP, ChenGJ, BergerDH. Infectious postoperative complications decrease long-term survival in patients undergoing curative surgery for colorectal cancer: A study of 12,075 patients. Ann Surg, 2015; 261:497–505.
27.
van der PasMH, HaglindE, CuestaMA, et al.Laparoscopic versus open surgery for rectal cancer (COLOR II): Short-term outcomes of a randomised, phase 3 trial. Lancet Oncol, 2013; 14:210–218.
28.
KangSB, ParkJW, JeongSY, et al.Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): Short-term outcomes of an open-label randomised controlled trial. Lancet Oncol, 2010; 11:637–645.
29.
Quasar CollaborativeG, GrayR, BarnwellJ, et al.Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study. Lancet, 2007; 370:2020–2029.
30.
FigueredoA, CharetteML, MarounJ, BrouwersMC, ZurawL. Adjuvant therapy for stage II colon cancer: A systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol, 2004; 22:3395–3407.
31.
NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA, 1990; 264:1444–1450.
32.
BensonAB3rd, SchragD, SomerfieldMR, et al.American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol, 2004; 22:3408–3419.
33.
PoultsidesGA, ServaisEL, SaltzLB, et al.Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol, 2009; 27:3379–3384.
34.
Van CutsemE, CervantesA, AdamR, et al.ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol, 2016; 27:1386–1422.
35.
SchmollHJ, Van CutsemE, SteinA, et al.ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol, 2012; 23:2479–2516.
36.
KeatingNL, LandrumMB, KlabundeCN, et al.Adjuvant chemotherapy for stage III colon cancer: Do physicians agree about the importance of patient age and comorbidity?. J Clin Oncol, 2008; 26:2532–2537.
37.
PopescuRA, NormanA, RossPJ, ParikhB, CunninghamD. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol, 1999; 17:2412–2418.
38.
MayerB, SanderS, PaschkeS, et al.Stratified survival analysis after adjuvant chemotherapy of colon cancer reveals a benefit for older patients. Anticancer Res, 2015; 35:5587–5593.
39.
KabbinavarFF, HurwitzHI, YiJ, SarkarS, RosenO. Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: Pooled analysis of cohorts of older patients from two randomized clinical trials. J Clin Oncol, 2009; 27:199–205
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
